3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Breast
1
Conditions
Lymphoma
335
Precursor Cell Lymphoblastic Leukemia-Lymphoma
292
Lymphoma, Large B-Cell, Diffuse
216
Lymphoma, Non-Hodgkin
192
Lymphoma, Follicular
172
Leukemia, Lymphocytic, Chronic, B-Cell
129
Lymphoma, B-Cell
123
Hodgkin Disease
112
Leukemia
104
Recurrence
100
Lymphoma, Mantle-Cell
89
Burkitt Lymphoma
88
Lymphoma, T-Cell, Peripheral
60
Lymphoma, Extranodal NK-T-Cell
56
Multiple Myeloma
53
Leukemia, Myeloid, Acute
53
Lymphoma, B-Cell, Marginal Zone
51
Lymphoma, T-Cell
41
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
39
Neoplasms
39
Leukemia, B-Cell
39
Lymphoma, T-Cell, Cutaneous
37
Lymphoma, Large-Cell, Immunoblastic
31
Myelodysplastic Syndromes
30
Hematologic Neoplasms
25
Mycosis Fungoides
24
Lymphoma, Large-Cell, Anaplastic
24
Neoplasms, Plasma Cell
23
Waldenstrom Macroglobulinemia
22
Immunoblastic Lymphadenopathy
22
Interventions
Nebivolol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Ventricular Dysfunction, Left
×
Lymphoid
×
Clear all
NCT05728632
2023-02-23
CONTROL
Humanitas Hospital, Italy
Phase 3
Unknown
80 enrolled